Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	SOX2 TPR PARP2 NUP98 CHD2 BRD3 PHF8 SIX1 ARID1A ADNP PHC2 TDRD3 SUPT16H AUTS2 MRNIP HMGN4 NIPBL OBI1	5.73e-05	739	169	18	GO:0003682
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	SOX2 SETD1A ETS2 ID4 GBX2 TACC2 ARID1A TRIP12 SNW1 CD34 AHR MED13	2.34e-04	417	169	12	GO:0061629
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	SCAF8 POLR2M SCAF1 CTR9 AHR	2.41e-04	66	169	5	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	SCAF8 POLR2M SCAF1 CTR9 AHR	2.41e-04	66	169	5	GO:0001098
GeneOntologyMolecularFunction	RNA polymerase II complex binding	SCAF8 POLR2M SCAF1 CTR9	3.23e-04	39	169	4	GO:0000993
GeneOntologyMolecularFunction	RNA polymerase core enzyme binding	SCAF8 POLR2M SCAF1 CTR9	5.63e-04	45	169	4	GO:0043175
GeneOntologyCellularComponent	nuclear protein-containing complex	DDX19B TPR SETD1A RBM44 MIS18BP1 MED29 SCAF8 ZC3H8 BACH2 NUP98 POLR2M ARID1A ADNP PHC2 WDR74 TDRD3 TAF8 SNW1 SMG7 CTR9 SUPT16H AHR MRNIP MGA NIPBL MED13 MX1	2.25e-05	1377	172	27	GO:0140513
GeneOntologyCellularComponent	chromatin	SOX2 SETD1A BAZ2B ZC3H8 BACH2 ETS2 GBX2 CHD2 BRD3 SIX1 ARID1A ADNP PHC2 SNW1 MORF4L2 CTR9 SUPT16H AHR PDS5A TNKS1BP1 ZBED1 MGA HMGN4 NIPBL OBI1 NR1D2 HOMEZ	7.77e-05	1480	172	27	GO:0000785
GeneOntologyCellularComponent	adherens junction	MAGI1 CDHR3 PIP5K1C LLGL2 EFNB2 HMCN1 FMN1 TNKS1BP1	3.81e-04	212	172	8	GO:0005912
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	CENPT ZNF148 MED29 CHD9 CHD2 BRD3 PHF8 ARID1A ADNP TRIP12 PHC2 ZNF800 TAF8 SUPT16H MGA HMGN4 NIPBL OBI1 CAP2	2.99e-11	533	174	19	30554943
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ZNF148 MED29 BAZ2B ZC3H8 PARP2 NUP98 G2E3 CHD2 BRD3 PHF8 RRBP1 ARID1A ADNP TRIP12 PHC2 BLM SCAF1 SNW1 MORF4L2 ZSCAN30 CTR9 SUPT16H PDS5A NKTR MGA HMGN4 NIPBL HOMEZ	6.94e-11	1294	174	28	30804502
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIS18BP1 CENPT ZNF148 LCORL BAZ2B CHD9 CHD2 BRD3 PHF8 ADNP TRIP12 BLM MORF4L2 SUPT16H PDS5A SNAPC4 MGA NIPBL HOMEZ	2.75e-10	608	174	19	36089195
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR ZNF148 SCAF8 NUP98 ARFGEF2 FAM91A1 BRD3 PHF8 RRBP1 TRIP12 PHC2 BLM SCAF1 CTR9 HELZ TNKS1BP1 SNAPC4 MAP4K4 NIPBL MED13 HOMEZ	3.89e-10	774	174	21	15302935
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF148 TTC28 BACH2 TNRC6B CHD9 BRD3 SCEL PHF8 ARID1A ANKHD1 JPH1 SLIT2 SCAF1 ZNF469 TAF8 ARHGEF33 SMG7 AGO3 MORF4L2 SUPT16H AHR HELZ UCK2 SIGLEC1 MGA	4.00e-10	1116	174	25	31753913
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	MIS18BP1 BAZ2B CHD9 PHF8 ADNP BLM SNW1 CTR9 SUPT16H PDS5A MGA NIPBL	1.49e-09	222	174	12	37071664
Pubmed	Human transcription factor protein interaction networks.	SOX2 SETD1A AHCYL1 ZNF148 SCAF8 NUP98 ID4 TNRC6B MYO1B PHF8 ARID1A ANKHD1 ADNP STAU1 BLM TAF8 SNW1 SMG7 AGO3 MORF4L2 AUTS2 HELZ PDS5A LSM14B MGA NIPBL HOMEZ	2.98e-09	1429	174	27	35140242
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AHCYL1 ANK3 TTC28 TRIO SIPA1L3 KIAA0319L ETS2 ARFGEF2 CHD9 NCKAP5 RRBP1 ARID1A TRIP12 ZNF251 JPH1 SCYL2 MORF4L2 MICAL2 CTR9 SCG2 MAP4K4 NIPBL MED13 CAP2 NR1D2	6.88e-09	1285	174	25	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1A G2E3 RRBP1 ANKHD1 ADNP ADGRA2 SMG7 PLPPR4 MORF4L2 AUTS2 TNKS1BP1 MAP4K4 FAIM2 MED13 IGSF3 HOMEZ	1.20e-08	529	174	16	14621295
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETD1A ZNF148 TTC28 NUP98 CHD2 BRD3 ARID1A TRIP12 SNW1 MORF4L2 N4BP2 SUPT16H PDS5A TNKS1BP1 LSM14B	1.68e-08	469	174	15	27634302
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR SETD1A ZNF148 ANK3 TTC28 TNRC6B PHF8 ARID1A ANKHD1 ADNP SCYL2 SNW1 SMG7 TNKS1BP1 MGA MAP4K4	2.00e-08	549	174	16	38280479
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 TPR ABI1 ANK3 TRIO SIPA1L3 TNRC6B GRIN2D ADNP TDRD3 GOLGA8M SNW1 AGO3 PLPPR4 N4BP2 SUPT16H MGA MAP4K4 NIPBL CAP2	8.89e-08	963	174	20	28671696
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 MAGI1 KCNH8 ANK3 TRIO SCAF8 ZC3H8 SIPA1L3 TNRC6B RTN4RL1 CHD9 G2E3 ATP9B CHD2 WDR25 RRBP1 ARID1A ADCY3 DNAH1 EFNB2 SMG7 MICAL2 AUTS2 CAP2 PDZD2	1.19e-07	1489	174	25	28611215
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	TNRC6B ANKHD1 STAU1 SMG7 AGO3 HELZ TNKS1BP1	1.62e-07	80	174	7	35803934
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CCDC14 MIS18BP1 CENPT TTC28 MED29 PARP2 TNRC6B FAM91A1 BRD3 TRIP12 PHC2 MORF4L2 SUPT16H HMGN4 MED13 CAP2	1.80e-07	645	174	16	25281560
Pubmed	A human MAP kinase interactome.	CCDC14 MAGI1 TPR ANK3 NUP98 NCKAP5 N4BP2 CEP250 HELZ NKTR MGA MAP4K4 OBI1 CAP2	1.84e-07	486	174	14	20936779
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PRUNE2 TTC28 SIPA1L3 TNRC6B PHF8 RRBP1 ADGRA2 SMG7 AUTS2 TNKS1BP1	2.25e-07	225	174	10	12168954
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CCDC14 SCAF8 SIPA1L3 TNRC6B STAU1 SCYL2 SNW1 SMG7 MGA	4.12e-07	184	174	9	32908313
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 SETD1A TRIO SIPA1L3 KIAA0319L ARFGEF2 GBX2 GRIN2D ARID1A ANKHD1 PIP5K1C ADGRA2 PHC2 SCAF1 TDRD3 LLGL2 TNKS1BP1 SNAPC4 MED13 IGSF3	7.76e-07	1105	174	20	35748872
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	SETD1A PARP2 CHD9 CHD2 BRD3 RRBP1 ARID1A TRIP12 PHC2 BLM SUPT16H PDS5A	7.95e-07	394	174	12	27248496
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TPR MIS18BP1 MED29 NUP98 CHD9 CHD2 BRD3 PHF8 RRBP1 ADNP PHC2 BLM SNW1 CTR9 SUPT16H PDS5A HMGN4 NIPBL MED13	8.96e-07	1014	174	19	32416067
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR NUP98 MYO1B CHD2 ARID1A ANKHD1 ADNP TRIP12 STAU1 BLM SNW1 HELZ PDS5A TNKS1BP1 NIPBL	1.16e-06	653	174	15	22586326
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TPR SETD1A AHCYL1 MIS18BP1 MYO1B CHD2 PHF8 RRBP1 ARID1A ANKHD1 ADNP TRIP12 STAU1 BLM WDR74 SNW1 MICAL2 CTR9 SUPT16H PDS5A MGA NIPBL	1.24e-06	1353	174	22	29467282
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR ZNF148 TTC28 LCORL TNRC6B ANKHD1 ADNP N4BP2 TNKS1BP1 MGA OBI1 HOMEZ	1.47e-06	418	174	12	34709266
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	PRTG TRIO ADGRA2 HMCN1 SIGLEC1 MDGA1 ADGRA3 IGSF3	1.71e-06	162	174	8	25826454
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MIS18BP1 TTC28 BACH2 MYO1B TACC2 ARID1A BLM TDRD3 SMG7 CTR9 N4BP2 HELZ TNKS1BP1 OBI1	1.76e-06	588	174	14	38580884
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ABI1 SCAF8 SIPA1L3 PARP2 TNRC6B FAM91A1 CHD2 BRD3 ANKHD1 PHC2 BLM SCAF1 TDRD3 ZNF800 TAF8 FGD4 MORF4L2 CTR9 HELZ PDS5A LSM14B NIPBL MED13	1.82e-06	1497	174	23	31527615
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	SOX2 MED29 ARID1A ADNP SNW1 SUPT16H MGA MED13	2.15e-06	167	174	8	20362541
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ZC3H8 TNRC6B CHD9 MYO1B CHD2 BRD3 ARID1A ADNP TRIP12 PHC2 STAU1 BLM SNW1 MORF4L2 SUPT16H PDS5A TNKS1BP1 MAP4K4 NIPBL	2.32e-06	1082	174	19	38697112
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	CCDC14 MIS18BP1 TNRC6B SCYL2 TDRD3 SMG7 N4BP2 MGA	2.35e-06	169	174	8	31462741
Pubmed	Probing nuclear pore complex architecture with proximity-dependent biotinylation.	DDX19B TPR NUP98 FMN1 CEP250 PDZD2	2.54e-06	77	174	6	24927568
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	AHCYL1 ZNF148 TNRC6B TACC2 ADNP STAU1 BLM SNW1 PDS5A TNKS1BP1 LSM14B MGA	2.74e-06	444	174	12	34795231
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	PHF8 ADNP PHC2 TAF8 MORF4L2 MGA NIPBL	3.20e-06	124	174	7	20850016
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX2 ZNF438 ZNF148 LCORL ZC3H8 BACH2 ETS2 GBX2 BRD3 PHF8 ARID1A ZUP1 AHR SNAPC4 MGA NR1D2	3.41e-06	808	174	16	20412781
Pubmed	A protein interaction landscape of breast cancer.	TPR ZNF148 ANK3 TTC28 TRIO SIPA1L3 MYO1B RRBP1 ARID1A STAU1 MICAL2 SUPT16H AHR PDS5A	4.19e-06	634	174	14	34591612
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	DDX19B MAGI1 TPR AHCYL1 SIPA1L3 NUP98 TNRC6B CHD9 MYO1B RRBP1 ARID1A TRIP12 STAU1 DNAH1 SNW1 MICAL2 AHR TNKS1BP1 MGA MED13	4.82e-06	1247	174	20	27684187
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR ZNF148 NUP98 TNRC6B MYO1B TACC2 RRBP1 ANKHD1 ADNP STAU1 SCYL2 TDRD3 SNW1 SMG7 HELZ TNKS1BP1 NIPBL	5.10e-06	934	174	17	33916271
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CCDC14 ANK3 TRIO SIPA1L3 NUP98 FAM91A1 MYO1B BRD3 PHF8 ARID1A BLM TDRD3 SMG7 CTR9 SSH3 SUPT16H HELZ CAP2	5.97e-06	1049	174	18	27880917
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR CENPT ZNF148 BAZ2B NUP98 RRBP1 ARID1A ADNP TRIP12 STAU1 BLM SNW1 SUPT16H PDS5A MGA HMGN4 NIPBL	6.73e-06	954	174	17	36373674
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CCDC14 MIS18BP1 TTC28 TRIO BACH2 SIPA1L3 KIAA0319L TNRC6B FAM91A1 PHF8 SMG7 AGO3 N4BP2 CEP250 MGA MAP4K4	6.74e-06	853	174	16	28718761
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR ABI1 ZNF148 PARP2 NUP98 ID4 RRBP1 SIX1 ANKHD1 ADNP TRIP12 BLM MORF4L2 PDS5A MGA OBI1	7.15e-06	857	174	16	25609649
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FNIP2 TTC28 TSPOAP1 SCAF8 TNRC6B FAM91A1 PHF8 PIP5K1C ADCY3 FAIM2 PDZD2	7.20e-06	407	174	11	12693553
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ANK3 TTC28 KIAA0319L NUP98 ARFGEF2 MUC16 TNRC6B FAM91A1 TRIP12 BLM EFNB2 OSBPL2 PDS5A MGA IGSF3	9.43e-06	777	174	15	35844135
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR ZNF148 NUP98 TACC2 RRBP1 TRIP12 BLM CTR9 SSH3 TNKS1BP1 NIPBL OBI1	9.67e-06	503	174	12	16964243
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	DDX19B ZNF148 MED29 LCORL BAZ2B CHD9 ARID1A ADNP STAU1 WDR74 SNW1 CELF2 CTR9 PDS5A LSM14B HMGN4 NIPBL HOMEZ	1.18e-05	1103	174	18	34189442
Pubmed	ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation.	TRIO SCAF8 ARID1A CTR9 SUPT16H	1.19e-05	59	174	5	34108663
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PRUNE2 SETD1A ANK3 TSPOAP1 NUP98 ADNP PIP5K1C TRIP12 ZNF469 MGA PLEKHO1	1.20e-05	430	174	11	35044719
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	DDX19B MIS18BP1 ETS2 ATP9B ZNF251 BLM HMCN1	1.22e-05	152	174	7	34299191
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	TRIO SIPA1L3 TRIP12 HELZ PDS5A TNKS1BP1 NKTR MAP4K4	1.24e-05	212	174	8	33853758
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	G2E3 RRBP1 DNAH1 SCYL2 N4BP2 NYNRIN HOMEZ	1.28e-05	153	174	7	10718198
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MAGI1 TPR AHCYL1 ANK3 TTC28 TNRC6B MYO1B RRBP1 STAU1 JPH1 SCYL2 PDS5A TNKS1BP1 MAP4K4	1.45e-05	708	174	14	39231216
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX2 MIS18BP1 CENPT ZNF148 LCORL BACH2 ETS2 ID4 GBX2 SIX1 ADNP SNAPC4 ZBED1 MGA NR1D2 HOMEZ	1.46e-05	908	174	16	19274049
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1A NUP98 RRBP1 ARID1A ADNP TRIP12 STAU1 BLM CTR9 SUPT16H NKTR	1.49e-05	440	174	11	34244565
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	TNRC6B RRBP1 ANKHD1 TRIP12 STAU1 SLIT2 TDRD3 SNW1 SMG7 AGO3 CELF2 HELZ LSM14B MGA	1.86e-05	724	174	14	36232890
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	SOX2 CHD9 TRIP12 STAU1 SUPT16H MGA	1.90e-05	109	174	6	33554859
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SIPA1L3 TNRC6B FAM91A1 MYO1B CHD2 RRBP1 ANKHD1 TRIP12 PHC2 STAU1 WDR74 SCAF1 SNW1 AGO3 SUPT16H AHR COL14A1 PIMREG NKTR LSM14B	1.91e-05	1371	174	20	36244648
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	AHCYL1 TTC28 TRIO ANKHD1 GOLGA8M SNW1 SUPT16H UCK2	2.24e-05	230	174	8	35449600
Pubmed	SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.	SOX2 MAP4K4	2.49e-05	2	174	2	24233838
Pubmed	Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice.	ADCY4 ADCY3	2.49e-05	2	174	2	11055432
Pubmed	Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients.	SOX2 ABCC2	2.49e-05	2	174	2	32727778
Pubmed	Evaluation of candidate spermatogonial markers ID4 and GPR125 in testes of adult human cadaveric organ donors.	ID4 ADGRA3	2.49e-05	2	174	2	24902969
Pubmed	The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR.	TPR NUP98	2.49e-05	2	174	2	11248057
Pubmed	ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.	SOX2 ID4	2.49e-05	2	174	2	21531766
Pubmed	ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2.	ARID1A ABCC2	2.49e-05	2	174	2	29660381
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAGI1 ABI1 ANK3 SIPA1L3 FAM91A1 MYO1B SCEL SCYL2 FMN1 SSH3 TNKS1BP1 ARHGAP18	3.03e-05	565	174	12	25468996
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MAGI1 AHCYL1 ABI1 KIAA0319L ARFGEF2 JPH1 LLGL2 MICAL2 ABCC2 FYB1 MAP4K4 IGSF3	3.25e-05	569	174	12	30639242
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	SOX2 ADNP PHC2 CTR9 SUPT16H PDS5A MGA	3.26e-05	177	174	7	26206133
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	AHCYL1 PCDHGB6 PCDHGA11 SIPA1L3 NUP98 MYO1B CHD2 BRD3 RRBP1 ARID1A TRIP12 CTR9 N4BP2 SUPT16H ABCC2 TSACC HMGN4 NIPBL OBI1 MED13	3.88e-05	1442	174	20	35575683
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ANK3 COL6A6 CHD9 CHD2 BRD3 RRBP1 TRIP12 BLM WDR74 KIF19 MAP4K4	4.52e-05	497	174	11	36774506
Pubmed	Functional proteomics mapping of a human signaling pathway.	ANK3 ETS2 ARFGEF2 RRBP1 TRIP12 ZNF251 STAU1 SCYL2 CTR9 CEP250 MGA CAP2	4.68e-05	591	174	12	15231748
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	FNIP2 MROH9 SETD1A AHCYL1 MIS18BP1 ADAMTS3 BACH2 PHTF2 CHD9 PIP5K1C AGO3 CTR9 CEP250 MRNIP SNAPC4 ARHGAP18 MX1 HOMEZ	5.55e-05	1242	174	18	30973865
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	MIS18BP1 ANK3 TTC28 TNRC6B ARID1A SMG7 HELZ MAP4K4	5.78e-05	263	174	8	34702444
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	TPR MIS18BP1 BAZ2B NUP98 TRIP12 WDR74 CEP250 SUPT16H NIPBL	5.84e-05	340	174	9	29478914
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	DDX19B SETD1A NUP98 BRD3 ARID1A SUPT16H PDS5A	6.02e-05	195	174	7	19454010
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	DDX19B MAGI1 TPR AHCYL1 TRIO NUP98 PIP5K1C JPH1 WDR74 FGD4 PDS5A NKTR ARHGAP18 MGA HMGN4	6.24e-05	916	174	15	32203420
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	SOX2 ZNF148 ARID1A ADNP NIPBL	6.27e-05	83	174	5	28794006
Pubmed	Genetic Ablation of Type III Adenylyl Cyclase Exerts Region-Specific Effects on Cilia Architecture in the Mouse Nose.	PDE1C ADCY3	7.44e-05	3	174	2	26942602
Pubmed	Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion.	TPR NUP98	7.44e-05	3	174	2	20407419
Pubmed	Direct binding of the human homologue of the Drosophila disc large tumor suppressor gene to seven-pass transmembrane proteins, tumor endothelial marker 5 (TEM5), and a novel TEM5-like protein.	ADGRA2 ADGRA3	7.44e-05	3	174	2	15021905
Pubmed	Identification of dynamic undifferentiated cell states within the male germline.	SOX2 ID4	7.44e-05	3	174	2	30026551
Pubmed	Skip is essential for Notch signaling to induce Sox2 in cerebral arteriovenous malformations.	SOX2 SNW1	7.44e-05	3	174	2	31927035
Pubmed	Molecular genetic characterization and comparative mapping of the human PCP4 gene.	ETS2 MX1	7.44e-05	3	174	2	8914602
Pubmed	Interaction network of human early embryonic transcription factors.	SETD1A AHCYL1 ZNF148 NUP98 ARID1A AUTS2 MGA NIPBL HOMEZ	7.44e-05	351	174	9	38297188
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TTC28 TRIO SCAF8 TNRC6B RRBP1 STAU1 JPH1 TDRD3 CUEDC2 N4BP2 HELZ MGA MAP4K4	8.89e-05	733	174	13	34672954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MROH9 BAZ2B ID4 CHD2 BRD3 PHF8 TRIP12 SCAF1 KY TDRD3 ARHGEF33 AHR PDS5A	9.26e-05	736	174	13	29676528
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TTC28 TRIO SIPA1L3 TNRC6B RRBP1 TDRD3 TNKS1BP1	9.30e-05	209	174	7	36779422
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SOX2 AHCYL1 BAZ2B CHD9 ARID1A PHC2 SCYL2 CTR9	9.38e-05	282	174	8	23667531
Pubmed	Generalization of variants identified by genome-wide association studies for electrocardiographic traits in African Americans.	MAGI1 HMCN1 MICAL2	9.50e-05	18	174	3	23534349
Pubmed	Olig2 regulates terminal differentiation and maturation of peripheral olfactory sensory neurons.	SOX2 ARFGEF2 ADCY3	9.50e-05	18	174	3	31758234
Pubmed	Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing.	TNRC6B CHD2 AUTS2	9.50e-05	18	174	3	30111840
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	SETD1A ZNF148 SCAF8 PARP2 NUP98 CHD2 RRBP1 ADNP TRIP12 WDR74 SCAF1 SNW1 CELF2 CTR9 SUPT16H HELZ NKTR NIPBL	1.17e-04	1318	174	18	30463901
Pubmed	Simultaneous Loss of NCKX4 and CNG Channel Desensitization Impairs Olfactory Sensitivity.	ADCY3 SLC24A4	1.48e-04	4	174	2	28053034
Pubmed	Association studies of low-frequency coding variants in nonsyndromic cleft lip with or without cleft palate.	PRTG N4BP2	1.48e-04	4	174	2	28425186
Pubmed	Six1 is essential for differentiation and patterning of the mammalian auditory sensory epithelium.	SOX2 SIX1	1.48e-04	4	174	2	28892484
Pubmed	Differential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.	SOX2 ID4	1.48e-04	4	174	2	23613880
Pubmed	Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export.	TPR NUP98	1.48e-04	4	174	2	11839768
Pubmed	Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex.	ARID1A ADNP	1.48e-04	4	174	2	17878164
Pubmed	Linkage mapping of microdissected clones from distal mouse chromosome 16.	ETS2 MX1	1.48e-04	4	174	2	8914607
Pubmed	EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway.	TNRC6B RRBP1 TNKS1BP1	1.53e-04	21	174	3	33029523
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	BRD3 ADNP TRIP12 SNW1 SUPT16H	1.74e-04	103	174	5	32744500
Interaction	BRD3 interactions	CENPT ZNF148 CHD9 BRD3 PHF8 ARID1A ADNP TRIP12 PHC2 JPH1 SCAF1 TAF8 SUPT16H SIGLEC1 MGA HMGN4 NIPBL CAP2	2.72e-07	494	173	18	int:BRD3
Interaction	CNOT9 interactions	SCAF8 TNRC6B ANKHD1 TDRD3 SMG7 AGO3 N4BP2 HELZ TNKS1BP1 MGA MAP4K4 OBI1	7.74e-07	231	173	12	int:CNOT9
Interaction	CNOT6L interactions	TNRC6B SMG7 AGO3 N4BP2 HELZ TNKS1BP1 MAP4K4 OBI1	1.37e-06	93	173	8	int:CNOT6L
Interaction	NUP43 interactions	SETD1A MIS18BP1 CENPT BAZ2B NUP98 TNRC6B CHD9 PHF8 ARID1A TRIP12 BLM SCAF1 CEP250 SUPT16H NKTR MGA NIPBL NR1D2 PDZD2	1.91e-06	625	173	19	int:NUP43
Interaction	ANKRD17 interactions	SOX2 TNRC6B ANKHD1 STAU1 TDRD3 SMG7 AGO3 N4BP2 HELZ TNKS1BP1 OBI1	4.24e-06	226	173	11	int:ANKRD17
Interaction	TNRC6A interactions	SOX2 TNRC6B ARID1A STAU1 SMG7 AGO3 NYNRIN CEP250 HELZ TNKS1BP1 OBI1 MED13	5.71e-06	280	173	12	int:TNRC6A
Interaction	FAM120C interactions	TNRC6B STAU1 TDRD3 SMG7 AGO3 CELF2 N4BP2 NYNRIN HELZ LSM14B	6.17e-06	191	173	10	int:FAM120C
Interaction	N4BP2 interactions	TNRC6B STAU1 TDRD3 N4BP2 CEP250 SNAPC4 OBI1	1.16e-05	89	173	7	int:N4BP2
Interaction	RBMS1 interactions	SOX2 TNRC6B RRBP1 STAU1 TDRD3 SMG7 AGO3 CELF2 N4BP2 HELZ	1.25e-05	207	173	10	int:RBMS1
Interaction	GARRE1 interactions	TNRC6B SCYL2 TDRD3 SMG7 AGO3 N4BP2 HELZ TNKS1BP1 OBI1	1.44e-05	167	173	9	int:GARRE1
Interaction	C11orf52 interactions	MAGI1 AHCYL1 ABI1 ANK3 TRIO SIPA1L3 MYO1B JPH1 SCYL2 EFNB2 MAP4K4 IGSF3	1.64e-05	311	173	12	int:C11orf52
Interaction	KDM1A interactions	SOX2 CCDC14 TPR ZNF148 TTC28 LCORL TNRC6B PHF8 ANKHD1 ADNP PHC2 LLGL2 SMG7 N4BP2 SUPT16H PDS5A TNKS1BP1 TSACC ZBED1 MGA OBI1 HOMEZ	1.94e-05	941	173	22	int:KDM1A
Interaction	TRIM52 interactions	CCDC14 MIS18BP1 FAM91A1 CTR9 NYNRIN AHR SNAPC4 MGA	1.98e-05	133	173	8	int:TRIM52
Interaction	TOP3B interactions	VWA5B2 DDX19B SETD1A TRIO SIPA1L3 KIAA0319L ARFGEF2 TNRC6B GBX2 MYO1B GRIN2D ARID1A ANKHD1 PIP5K1C ADGRA2 PHC2 STAU1 SCAF1 TDRD3 LLGL2 SMG7 SUPT16H HELZ TNKS1BP1 SNAPC4 LSM14B HMGN4 MED13 IGSF3	2.11e-05	1470	173	29	int:TOP3B
Interaction	TLE3 interactions	SOX2 AHCYL1 ANK3 BAZ2B SCAF8 MYO1B SIX1 ARID1A SMG7 AUTS2 HELZ TNKS1BP1 NIPBL	2.31e-05	376	173	13	int:TLE3
Interaction	CENPA interactions	MIS18BP1 CENPT ZNF148 PARP2 FAM91A1 BRD3 PHF8 TRIP12 PHC2 BLM SUPT16H PDS5A NIPBL	2.37e-05	377	173	13	int:CENPA
Interaction	CNOT2 interactions	TNRC6B ANKHD1 TDRD3 SMG7 AGO3 N4BP2 HELZ TNKS1BP1 OBI1	2.39e-05	178	173	9	int:CNOT2
Interaction	H3-3A interactions	SETD1A CENPT ZNF148 LCORL PARP2 CHD9 CHD2 BRD3 PHF8 ADNP TRIP12 BLM MORF4L2 SUPT16H PDS5A SNAPC4 MGA NIPBL HOMEZ	2.49e-05	749	173	19	int:H3-3A
Interaction	CNOT7 interactions	TNRC6B TDRD3 SMG7 AGO3 N4BP2 HELZ TNKS1BP1 OBI1	2.86e-05	140	173	8	int:CNOT7
Interaction	H3C1 interactions	TPR SETD1A CENPT ANK3 PARP2 BRD3 PHF8 RRBP1 ADNP TRIP12 STAU1 DNAH1 BLM SNW1 CTR9 SUPT16H PDS5A MGA HMGN4 NIPBL PDZD2	3.18e-05	901	173	21	int:H3C1
Interaction	ZFPL1 interactions	AHCYL1 ABI1 ANK3 TRIO ARFGEF2 FAM91A1 MYO1B JPH1 SCYL2 EFNB2 OSBPL2 TNKS1BP1 MAP4K4 PLEKHO1	3.40e-05	448	173	14	int:ZFPL1
Interaction	DAZL interactions	TNRC6B TDRD3 SMG7 AGO3 CELF2 N4BP2 HELZ LSM14B	3.68e-05	145	173	8	int:DAZL
Interaction	LZTS2 interactions	SOX2 TPR MIS18BP1 ANK3 TTC28 SIPA1L3 TNRC6B STAU1 SNW1 SMG7 AGO3 MORF4L2 N4BP2 CEP250 HELZ	3.72e-05	512	173	15	int:LZTS2
Interaction	SMAP2 interactions	TNRC6B STAU1 SCYL2 TDRD3 SMG7 N4BP2 HELZ ARHGAP18 SLC2A12	3.83e-05	189	173	9	int:SMAP2
Interaction	CELF1 interactions	PDE1C SCAF8 TNRC6B ANKHD1 STAU1 TDRD3 SMG7 AGO3 CELF2 NYNRIN HELZ	4.08e-05	288	173	11	int:CELF1
Interaction	CBX3 interactions	SOX2 SETD1A MIS18BP1 CENPT ZNF148 CHD9 BRD3 ADNP TRIP12 BLM SNW1 SUPT16H PDS5A TNKS1BP1 MGA MAP4K4 NIPBL	4.32e-05	646	173	17	int:CBX3
Interaction	CTIF interactions	DDX19B AHCYL1 TNRC6B TDRD3 SMG7 AGO3	5.25e-05	77	173	6	int:CTIF
Interaction	PHIP interactions	TPR TNRC6B BRD3 ANKHD1 STAU1 SMG7 AGO3 SUPT16H HELZ	5.29e-05	197	173	9	int:PHIP
Interaction	EIF4ENIF1 interactions	TNRC6B ANKHD1 STAU1 TDRD3 SMG7 AGO3 CELF2 CEP250 HELZ ARHGAP18 LSM14B	5.90e-05	300	173	11	int:EIF4ENIF1
Interaction	NIN interactions	SOX2 CCDC14 ABI1 TTC28 TRIO BACH2 SIPA1L3 TNRC6B SNW1 SMG7 CEP250 MGA	6.63e-05	359	173	12	int:NIN
Interaction	FANCD2OS interactions	AUTS2 TNKS1BP1 MAP4K4 OBI1	6.77e-05	26	173	4	int:FANCD2OS
Interaction	AMOT interactions	CCDC14 MAGI1 SIPA1L3 TNRC6B STAU1 SCYL2 SMG7 N4BP2 CEP250 MAP4K4 OBI1	8.37e-05	312	173	11	int:AMOT
Interaction	SMG5 interactions	ANK3 TNRC6B STAU1 TDRD3 SMG7 OBI1	8.57e-05	84	173	6	int:SMG5
Interaction	H3C3 interactions	MIS18BP1 ZNF148 LCORL BAZ2B BRD3 PHF8 ADNP TRIP12 BLM MORF4L2 SUPT16H PDS5A MGA NIPBL	9.88e-05	495	173	14	int:H3C3
Interaction	CSNK2B interactions	BAZ2B ARFGEF2 BRD3 PHF8 ADNP PHC2 STAU1 BLM CTR9 SUPT16H AUTS2 PDS5A PIMREG NKTR SNAPC4 MAP4K4	1.01e-04	625	173	16	int:CSNK2B
Interaction	MARF1 interactions	SOX2 TNRC6B STAU1 TDRD3 HELZ ARHGAP18 LSM14B	1.20e-04	128	173	7	int:MARF1
Interaction	MEX3B interactions	TNRC6B ANKHD1 TDRD3 SMG7 AGO3 CELF2 HELZ TNKS1BP1 LSM14B	1.32e-04	222	173	9	int:MEX3B
Interaction	H2BC8 interactions	MIS18BP1 CENPT ZNF148 PARP2 BRD3 ADNP TRIP12 PHC2 BLM SNW1 MORF4L2 SUPT16H PDS5A MGA NIPBL	1.39e-04	576	173	15	int:H2BC8
Interaction	PATL1 interactions	TNRC6B STAU1 TDRD3 SMG7 AGO3 N4BP2 HELZ ARHGAP18	1.49e-04	177	173	8	int:PATL1
Interaction	TNRC6B interactions	TNRC6B STAU1 TDRD3 SMG7 AGO3 N4BP2 HELZ TNKS1BP1 ARHGAP18 OBI1	1.68e-04	282	173	10	int:TNRC6B
Interaction	ZFP36 interactions	TNRC6B TDRD3 SMG7 AGO3 NYNRIN HELZ TNKS1BP1 LSM14B	1.74e-04	181	173	8	int:ZFP36
Interaction	VASP interactions	MAGI1 ABI1 SIPA1L3 TNRC6B SCYL2 SNW1 SMG7 CEP250 TNKS1BP1 FYB1	2.35e-04	294	173	10	int:VASP
Interaction	MIB1 interactions	CCDC14 MIS18BP1 TNRC6B SCYL2 BLM TDRD3 SMG7 N4BP2 CEP250 MGA	2.42e-04	295	173	10	int:MIB1
Interaction	FBRS interactions	SOX2 TNRC6B PHC2 AUTS2 HELZ MGA	2.50e-04	102	173	6	int:FBRS
Interaction	CPEB1 interactions	TNRC6B ANKHD1 STAU1 SMG7 AGO3 HELZ LSM14B	2.71e-04	146	173	7	int:CPEB1
Interaction	NAA40 interactions	SOX2 TPR ZNF148 PARP2 NUP98 TNRC6B MYO1B TACC2 RRBP1 ANKHD1 ADNP STAU1 SCYL2 TDRD3 SNW1 SMG7 SUPT16H HELZ TNKS1BP1 NIPBL	2.87e-04	978	173	20	int:NAA40
Interaction	DHX40 interactions	ZC3H8 PHF8 BLM SCAF1 SNW1 CTR9 SSH3 SUPT16H MGA	3.10e-04	249	173	9	int:DHX40
Interaction	CNOT1 interactions	SOX2 TNRC6B STAU1 TDRD3 SNW1 SMG7 HELZ TNKS1BP1 MAP4K4 OBI1	3.15e-04	305	173	10	int:CNOT1
Interaction	SYT2 interactions	SETD1A AHCYL1 CHD9 ADNP SMG7 CTR9 MAP4K4	3.20e-04	150	173	7	int:SYT2
Interaction	POLR1G interactions	BAZ2B CHD9 POLR2M CHD2 BRD3 PHF8 TRIP12 BLM CTR9 SUPT16H PDS5A MGA NIPBL	3.20e-04	489	173	13	int:POLR1G
Interaction	H2BC21 interactions	PARP2 FAM91A1 PHF8 ARID1A ADNP TRIP12 PHC2 BLM MORF4L2 CTR9 SUPT16H FYB1 MAP4K4 HMGN4 NIPBL IGSF3	3.39e-04	696	173	16	int:H2BC21
Interaction	ELOF1 interactions	TRIO SCAF8 ARID1A CTR9 SUPT16H	3.62e-04	71	173	5	int:ELOF1
GeneFamily	Immunoglobulin like domain containing\|Adhesion G protein-coupled receptors, subfamily A	ADGRA2 ADGRA3	1.37e-04	3	123	2	911
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG TRIO HMCN1 SIGLEC1 MDGA1 ADGRA3	8.19e-04	161	123	6	593
GeneFamily	Nucleoporins	DDX19B TPR NUP98	1.32e-03	32	123	3	1051
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY4 ADCY3	1.99e-03	10	123	2	53
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ABI1 ZNF148 TTC28 TRIO BAZ2B SCAF8 NUP98 CHD9 MYO1B PHF8 ADNP TRIP12 BLM SLIT2 TDRD3 SNW1 MICAL2 HELZ UCK2 PDS5A NIPBL MED13 ADGRA3 CAP2	2.19e-09	856	172	24	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	ABI1 ZNF148 TRIO BAZ2B SCAF8 NUP98 CHD9 MYO1B TRIP12 BLM HELZ UCK2 PDS5A MED13 CAP2	4.88e-07	466	172	15	M13522
Coexpression	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP	TTC28 BACH2 ETS2 TACC2 ADGRA2 STAU1 WDR74 SIGLEC1 CAP2 NR1D2	7.99e-07	198	172	10	M9035
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PRUNE2 ANK3 TTC28 TNRC6B CHD9 NCKAP5 SLIT2 FGD4 PDZD2	1.64e-05	221	172	9	M39222
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	CCDC14 TPR BAZ2B BRD3 SUPT16H NKTR	2.89e-05	90	172	6	M39250
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ZNF148 BAZ2B CHD9 ADNP PHC2 EFNB2 MICAL2 AHR AUTS2 HELZ	3.11e-05	300	172	10	M8702
Coexpression	DURAND_STROMA_S_UP	PRUNE2 BACH2 RTN4RL1 NCKAP5 SIX1 ADCY3 TRAM1L1 NYNRIN AHR FYB1	3.11e-05	300	172	10	M2581
Coexpression	DURAND_STROMA_S_UP	PRUNE2 BACH2 RTN4RL1 NCKAP5 SIX1 ADCY3 TRAM1L1 NYNRIN AHR FYB1	3.48e-05	304	172	10	MM1083
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	CCDC14 PRUNE2 SCAF8 BRD3 ADNP KIF3C ADGRA3 PDZD2	4.97e-05	197	172	8	M9862
Coexpression	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP	TRIO ATP9B ADNP TRIP12 PHC2 STAU1 AGO3 MED13	5.15e-05	198	172	8	M6166
Coexpression	GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	CHD9 SLC12A8 GRIN2D SCYL2 AGO3 PLEKHO1 NIPBL MX1	5.53e-05	200	172	8	M3411
Coexpression	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP	POLR2M ADGRA2 PHC2 SNW1 EFNB2 CUEDC2 SUPT16H NIPBL	5.53e-05	200	172	8	M6486
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	TPR ZNF148 ARFGEF2 ADNP STAU1 MORF4L2	8.92e-05	110	172	6	M19076
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	SOX2 SETD1A RBM44 ABI1 MIS18BP1 ZNF148 LCORL PHTF2 CHD9 G2E3 CHD2 ANKHD1 SLIT2 ZNF800 AGO3 HMCN1 DDX25 NKTR LRRN4 MGA	4.67e-06	776	171	20	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	SOX2 ANKRD29 ZNF148 ADAMTS3 LCORL BACH2 PHTF2 NCKAP5 SCEL SIX1 SLIT2 TDRD3 EFNB2 HMCN1 SUPT16H AUTS2 COL14A1 MED13 ADGRA3 IGSF3	1.39e-05	836	171	20	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	SOX2 TPR AHCYL1 ANK3 TRIO ADAMTS3 ARFGEF2 SIX1 TRIP12 SCYL2 EFNB2 HMCN1 FGD4 CTR9 SUPT16H MED13 CAP2 IGSF3 PDZD2	2.83e-05	806	171	19	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	ANKRD29 ZNF148 ADAMTS3 LCORL MYO1B NCKAP5 BLM SLIT2 TDRD3 AGO3 HMCN1 AUTS2 ADGRA3 IGSF3	3.44e-05	478	171	14	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	MAGI1 ID4 TNRC6B NCKAP5 CHD2 ANKHD1 ZUP1 JPH1 SCYL2 TDRD3 ZNF800 TRAM1L1 CEP250 SUPT16H ZFYVE19 PDS5A NKTR NIPBL CAP2	4.28e-05	831	171	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	SOX2 ANKRD29 ZNF148 ADAMTS3 LCORL BACH2 MYO1B NCKAP5 SCEL SIX1 BLM SLIT2 TDRD3 AGO3 HMCN1 AUTS2 COL14A1 ADGRA3 IGSF3	5.79e-05	850	171	19	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	MAGI1 MIS18BP1 TTC28 ARFGEF2 TNRC6B CHD2 ANKHD1 ZUP1 SCYL2 TDRD3 TRAM1L1 CEP250 SUPT16H ZFYVE19 NKTR SNAPC4 NIPBL CAP2	6.11e-05	780	171	18	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	SOX2 TPR ANK3 TTC28 TRIO ADAMTS3 BACH2 SIPA1L3 ARFGEF2 SIX1 ADGRA2 EFNB2 AGO3 HMCN1 MED13 CAP2 IGSF3 PDZD2	9.26e-05	806	171	18	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	SOX2 SETD1A RBM44 MIS18BP1 ZNF148 LCORL CHD9 G2E3 CHD2 SLIT2 LRRN4 MGA	1.25e-04	409	171	12	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	MAGI1 MIS18BP1 MUC16 PHF8 SCYL2 BLM SLIT2 TDRD3 HMCN1 MICAL2 NYNRIN CD34 COL14A1 LRRN4 FAIM2 PLEKHO1 ADGRA3 CAP2	1.28e-04	827	171	18	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500	ADAMTS3 MUC16 HMCN1 CELF2 COL14A1 LRRN4 C7 ARHGAP18 FYB1	1.48e-04	240	171	9	gudmap_kidney_adult_RenalCapsule_k1_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	DDX19B MAGI1 ID4 NCKAP5 JPH1 ZNF800 CELF2 FGD4 SUPT16H PDS5A	1.58e-04	298	171	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000	ADCY4 LCORL ETS2 RTN4RL1 MYO1B NCKAP5 POLR2M RRBP1 EFNB2 HMCN1 CD34 AHR UCK2 C7 ARHGAP18 FYB1 MAP4K4 PLEKHO1	1.72e-04	847	171	18	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	ANKRD29 ZNF148 LCORL PHTF2 NCKAP5 SLIT2 TDRD3 HMCN1 SUPT16H AUTS2 MED13 ADGRA3 IGSF3	1.84e-04	492	171	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	TPR AHCYL1 ANK3 TRIO ARFGEF2 TRIP12 SCYL2 FGD4 CTR9 SUPT16H MED13	2.08e-04	369	171	11	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_200	ADAMTS3 MUC16 COL14A1 LRRN4 C7 FYB1	2.68e-04	110	171	6	gudmap_kidney_adult_RenalCapsule_k3_200
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	SOX2 SETD1A RBM44 MIS18BP1 ZNF148 LCORL RTN4RL1 CHD9 G2E3 CHD2 ARID1A ANKHD1 SLIT2 NKTR LRRN4 MGA IGSF3	2.86e-04	806	171	17	gudmap_developingGonad_e12.5_epididymis_1000
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	MAGI1 PDE1C ID4 MUC16 TACC2 SIX1 EFNB2 SCG2 ADGRF1 SLC2A12 PDZD2	2.25e-10	188	174	11	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD29 MAGI1 ANK3 MYO1B TACC2 SCEL LLGL2 FGD4 MICAL2 FMN1 PDZD2	4.12e-10	199	174	11	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD29 MAGI1 ANK3 SIPA1L3 MYO1B TACC2 LLGL2 FGD4 MICAL2 FMN1 PDZD2	4.12e-10	199	174	11	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD29 MAGI1 ANK3 MYO1B NCKAP5 TACC2 SCEL LLGL2 MICAL2 PDZD2	5.40e-09	195	174	10	9406866f99555198a9be311fbd65751b70f35446
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADCY4 TRIO BAZ2B NCKAP5 HMCN1 AHR NKTR ARHGAP18 PLEKHO1 NIPBL	6.88e-09	200	174	10	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	ANKRD29 MAGI1 MYO1B NCKAP5 TACC2 SCEL LLGL2 MICAL2 PDZD2	3.79e-08	179	174	9	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 SIPA1L3 MYO1B SLC12A8 NCKAP5 SCEL LLGL2 LRRN4	5.04e-08	185	174	9	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	TRIO ARFGEF2 ADNP STAU1 ZNF469 CEP250 KIF3C LSM14B SLC2A12	5.78e-08	188	174	9	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 MYO1B SLC12A8 NCKAP5 SCEL LLGL2 MICAL2 PDZD2	6.33e-08	190	174	9	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ANK3 TTC28 TRIO TNRC6B NCKAP5 SLIT2 FGD4 PDZD2	6.93e-08	192	174	9	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZNF148 LCORL G2E3 ARID1A CTR9 N4BP2 PDS5A MGA MED13	7.24e-08	193	174	9	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD29 MAGI1 ANK3 MYO1B NCKAP5 TACC2 SCEL MICAL2 PDZD2	7.57e-08	194	174	9	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ANK3 TTC28 TRIO SIPA1L3 FGD4 FMN1 AUTS2 PDZD2	9.01e-08	198	174	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ANK3 MYO1B TACC2 LLGL2 FGD4 MICAL2 FMN1 PDZD2	9.41e-08	199	174	9	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD29 MAGI1 MYO1B TACC2 SCEL LLGL2 FGD4 MICAL2 PDZD2	9.41e-08	199	174	9	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ANK3 TTC28 TRIO BAZ2B SIPA1L3 TNRC6B FGD4 AUTS2	9.41e-08	199	174	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	ADCY4 BAZ2B ETS2 NCKAP5 AHR NKTR ARHGAP18 MAP4K4 PLEKHO1	9.82e-08	200	174	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	SETD1A ANK3 TRIO TNRC6B ADNP EFNB2 AUTS2 KIF3C MAP4K4	9.82e-08	200	174	9	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR CHD2 TRIP12 CELF2 HELZ NKTR SIGLEC1 NIPBL MX1	9.82e-08	200	174	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	FNIP2 SOX2 ZNF148 ANK3 BAZ2B ID4 CELF2 SCG2 AUTS2	9.82e-08	200	174	9	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ANK3 MUC16 SLC12A8 TACC2 RRBP1 LLGL2 FGD4 FMN1	9.82e-08	200	174	9	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ANKRD29 MAGI1 ANK3 MYO1B NCKAP5 TACC2 SCEL PDZD2	3.66e-07	170	174	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADCY4 TSPOAP1 USP29 PIMREG TNKS1BP1 ADGRA3 MX1	4.21e-07	118	174	7	5f72022f4be3fb7ccec86dc05d37572833028886
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADCY4 TSPOAP1 USP29 PIMREG TNKS1BP1 ADGRA3 MX1	4.21e-07	118	174	7	053c0986051e36fdc4c48b8067c137b6299b2f1b
ToppCell	Control-Lymphoid_T/NK-NK_activated\|Control / Disease group, lineage and cell class	ADCY4 TSPOAP1 USP29 PIMREG TNKS1BP1 ADGRA3 MX1	4.46e-07	119	174	7	a258d91ac90d4174b6f203d7f96ba6e57c6003e7
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADCY4 TSPOAP1 USP29 PIMREG TNKS1BP1 ADGRA3 MX1	4.46e-07	119	174	7	28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADCY4 TSPOAP1 USP29 PIMREG TNKS1BP1 ADGRA3 MX1	4.46e-07	119	174	7	0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE1C SLIT2 CELF2 ARHGAP18 ADGRF1 PDZD2 BAALC	4.76e-07	176	174	8	25ebc8716aa44e44fce577701e3e82c6745a75ab
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAGI1 ANK3 MYO1B TACC2 EFNB2 AHR AUTS2 IGSF3	6.40e-07	183	174	8	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	ANKRD29 MYO1B NCKAP5 TACC2 SCEL JPH1 LLGL2 MICAL2	6.40e-07	183	174	8	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD29 MAGI1 MYO1B NCKAP5 SCEL LLGL2 MICAL2 PDZD2	6.67e-07	184	174	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 MYO1B NCKAP5 TACC2 SCEL LLGL2 PDZD2	6.67e-07	184	174	8	561592edc3083fad41b91811151b442207c65dd9
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD29 MAGI1 MYO1B NCKAP5 SCEL LLGL2 MICAL2 PDZD2	6.67e-07	184	174	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 MYO1B SLC12A8 NCKAP5 SCEL LLGL2 PDZD2	6.95e-07	185	174	8	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 ANK3 MYO1B TACC2 LLGL2 MICAL2 PDZD2	9.19e-07	192	174	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MAGI1 ANK3 MYO1B TACC2 LLGL2 MICAL2 AUTS2 PDZD2	9.19e-07	192	174	8	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	TTC28 TNRC6B RRBP1 HELZ NKTR MAP4K4 NIPBL MED13	9.56e-07	193	174	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	ILEUM-inflamed-(3)_moDC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FNIP2 MIS18BP1 ETS2 FGD4 FMN1 AHR SIGLEC1 PLEKHO1	9.94e-07	194	174	8	c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 ANK3 MYO1B CHD2 TACC2 MICAL2 AUTS2 PDZD2	9.94e-07	194	174	8	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	ZNF438 ABI1 NCKAP5 ARID1A AGO3 KHDC3L LRRN4	1.05e-06	135	174	7	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	ANKRD29 COL6A6 ID4 CHD9 SLIT2 COL14A1 C7 MX1	1.12e-06	197	174	8	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	MAGI1 ADCY4 PDE1C TTC28 EFNB2 CD34 ARHGAP18 BAALC	1.12e-06	197	174	8	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC12A8 G2E3 NCKAP5 TACC2 SSTR1 PLPPR4 TM7SF2 FAIM2	1.12e-06	197	174	8	b8dc192fc98428bbb701cc2ea57fc8ad93397785
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD29 PDE1C ID4 MYO1B NCKAP5 ADCY3 PLPPR4 COL14A1	1.16e-06	198	174	8	b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739
ToppCell	medial-2-Epithelial-Alveolar_Epithelial_Type_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANKRD29 MYO1B NCKAP5 TACC2 SCEL LLGL2 MICAL2 LRRN4	1.20e-06	199	174	8	456460c761e26ed4b1d88d9bee4d2a7c9bd9d416
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SOX2 ANKRD29 MYO1B NCKAP5 TACC2 SCEL JPH1 LLGL2	1.20e-06	199	174	8	b44d74895846e2ac144438b73e0ca91e3949c16c
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SOX2 ANKRD29 MYO1B NCKAP5 TACC2 SCEL JPH1 LLGL2	1.20e-06	199	174	8	4b374a5de82b4614d3d8a00202ea6cb8f1fd8104
ToppCell	medial-Epithelial-Alveolar_Epithelial_Type_1-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANKRD29 MYO1B NCKAP5 TACC2 SCEL LLGL2 MICAL2 LRRN4	1.20e-06	199	174	8	5263338242f95c04690d0795749ccc20b0d19f7a
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SOX2 ANKRD29 MYO1B NCKAP5 TACC2 SCEL JPH1 LLGL2	1.20e-06	199	174	8	9e8231c9007d8d963805a4c99e0905538ceb9b60
ToppCell	medial-Epithelial-Alveolar_Epithelial_Type_1\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANKRD29 MYO1B NCKAP5 TACC2 SCEL LLGL2 MICAL2 LRRN4	1.20e-06	199	174	8	c11365653c69a5dfb37946231f8af05149a61a71
ToppCell	distal-1-mesenchymal-Lipofibroblast\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A6 ID4 SLIT2 ZNF469 SCG2 COL14A1 C7 FAIM2	1.20e-06	199	174	8	a8293db3c42a8d30897858b49aae7acfc18663ba
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SOX2 ANK3 BAZ2B MUC16 TACC2 SIX1 ARHGAP18 ADGRF1	1.25e-06	200	174	8	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADCY4 BAZ2B ETS2 NCKAP5 EFNB2 NKTR ARHGAP18 PLEKHO1	1.25e-06	200	174	8	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD29 MAGI1 PDE1C SLIT2 ARHGAP18 ADGRF1 BAALC	2.31e-06	152	174	7	9391b46a441cf031665df1d142e3f65e98675eeb
ToppCell	Control\|World / group, cell type (main and fine annotations)	MAGI1 ANK3 MYO1B NCKAP5 TACC2 MICAL2 PDZD2	4.49e-06	168	174	7	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD29 MAGI1 ID4 NCKAP5 TACC2 SCEL LLGL2	5.44e-06	173	174	7	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD29 MAGI1 PDE1C SLIT2 ARHGAP18 ADGRF1 BAALC	5.87e-06	175	174	7	1d8da48236549c01381f777ce5b2937f9f86acc2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE1C ADAMTS3 SIX1 ARHGAP18 ADGRF1 BAALC	6.09e-06	176	174	7	cb21342dd135cc80a50aafe7bf8bf31265db68dd
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 AHCYL1 ANK3 NCKAP5 LLGL2 CAP2 IGSF3	6.09e-06	176	174	7	36f77d878a53b30465b0dea8333a3865dba75613
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RTN4RL1 MYO1B SLC12A8 SLIT2 ZNF469 SLC24A4 PDZD2	6.56e-06	178	174	7	ccea3c8908d72f5fecd151a133048c8e9758304c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE1C SLIT2 CELF2 ARHGAP18 ADGRF1 BAALC	6.80e-06	179	174	7	e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD29 MYO1B NCKAP5 SCEL LLGL2 LRRN4 MDGA1	6.80e-06	179	174	7	d5e3e7f1cd8f683f39a7416f12af7e766dcbead8
ToppCell	15-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	VWA5B2 SOX2 PRUNE2 SIX1 SCG2 KIF19 TSACC	6.80e-06	179	174	7	bc04789f0fbd293fdcea66acba8cf227af251b7a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE1C SLIT2 CELF2 ARHGAP18 ADGRF1 BAALC	7.32e-06	181	174	7	30729f0364f719c044712a51453e22dc2c1a232b
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 ANKRD29 TACC2 ENAM EFNB2 TRAM1L1 MICAL2	7.58e-06	182	174	7	ebc812ed3f25839ea25f76b952c463d79a8325b1
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	ANKRD29 MAGI1 MYO1B NCKAP5 TACC2 SCEL LLGL2	7.58e-06	182	174	7	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 ANKRD29 TACC2 ENAM EFNB2 TRAM1L1 MICAL2	7.58e-06	182	174	7	47ff6b4002a4167412c79210651316d1342503f9
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANKRD29 MYO1B NCKAP5 TACC2 SCEL LLGL2 MICAL2	7.86e-06	183	174	7	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRIO BAZ2B ETS2 CHD9 CHD2 TRIP12 MX1	7.86e-06	183	174	7	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADAMTS3 MYO1B SLC12A8 SLIT2 ZNF469 SLC24A4 PDZD2	7.86e-06	183	174	7	1645d4a55cd8c22d6eb47fc5c6b1e576c454f111
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	MAGI1 PDE1C SLIT2 CELF2 ARHGAP18 ADGRF1 BAALC	7.86e-06	183	174	7	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	PRTG ANK3 TACC2 MICAL2 AUTS2 ADGRF1 PDZD2	8.14e-06	184	174	7	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 NCKAP5 TACC2 SCEL LLGL2 FGD4	8.14e-06	184	174	7	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ANKRD29 MYO1B NCKAP5 SCEL LLGL2 LRRN4 MDGA1	8.14e-06	184	174	7	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX2 PRUNE2 KCNH8 SIX1 KY PLPPR4 SCG2	8.14e-06	184	174	7	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADAMTS3 MYO1B SLC12A8 SLIT2 ZNF469 SLC24A4 PDZD2	8.14e-06	184	174	7	34e316ad8e7b8667cd8ad61397281802a252744f
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ANKRD29 MYO1B NCKAP5 SCEL LLGL2 LRRN4 MDGA1	8.14e-06	184	174	7	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX2 PRUNE2 KCNH8 SIX1 KY PLPPR4 SCG2	8.14e-06	184	174	7	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	ANKRD29 MAGI1 MYO1B NCKAP5 TACC2 SCEL LLGL2	8.44e-06	185	174	7	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE1C SLIT2 CELF2 ARHGAP18 ADGRF1 BAALC	8.44e-06	185	174	7	9438097e94219c1db922b8507e3a29106d32a923
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	MAGI1 ANK3 MYO1B NCKAP5 TACC2 AHR ADGRA3	8.74e-06	186	174	7	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 MYO1B SLC12A8 NCKAP5 SCEL LLGL2	8.74e-06	186	174	7	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ANK3 TTC28 CDHR3 SIPA1L3 SLC12A8 NCKAP5	8.74e-06	186	174	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	MAGI1 ANK3 MYO1B NCKAP5 TACC2 AHR ADGRA3	8.74e-06	186	174	7	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD29 CENPT MYO1B NCKAP5 SCEL LLGL2 MICAL2	9.05e-06	187	174	7	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	Control-Epithelial-ATI\|Control / Disease state, Lineage and Cell class	ANKRD29 MAGI1 MYO1B NCKAP5 TACC2 SCEL LLGL2	9.05e-06	187	174	7	fdd1c57b61ca9392ac27661a82729f37593df63c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 MYO1B SLC12A8 NCKAP5 SCEL LLGL2	9.05e-06	187	174	7	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 MYO1B NCKAP5 SCEL LLGL2 PDZD2	9.05e-06	187	174	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 ANK3 TACC2 SCEL LLGL2 MICAL2 PDZD2	9.37e-06	188	174	7	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE1C SLIT2 CELF2 FGD4 ADGRF1 BAALC	9.37e-06	188	174	7	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH8 TRIO MC5R SCEL SSTR1 KY DDX25	9.37e-06	188	174	7	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	MAGI1 ANK3 MYO1B TACC2 EFNB2 AHR IGSF3	9.37e-06	188	174	7	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH8 TRIO MC5R SCEL SSTR1 KY DDX25	9.37e-06	188	174	7	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MAGI1 ANK3 MYO1B TACC2 SCEL MICAL2 PDZD2	9.37e-06	188	174	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE1C SLIT2 CELF2 ARHGAP18 ADGRF1	9.39e-06	124	174	6	1fec6663cea40017438ead397b3bf8b3cdb67e58
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	SIPA1L3 TACC2 SCEL LLGL2 FGD4 FMN1 ADGRF1	9.70e-06	189	174	7	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	FNIP2 MAGI1 ANK3 NCKAP5 TACC2 JPH1 CAP2	9.70e-06	189	174	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	ANKRD29 MAGI1 MYO1B NCKAP5 SCEL LLGL2 PDZD2	9.70e-06	189	174	7	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	FNIP2 MAGI1 ANK3 NCKAP5 TACC2 JPH1 CAP2	1.00e-05	190	174	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 ADCY4 PDE1C TTC28 EFNB2 CD34 BAALC	1.00e-05	190	174	7	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
Drug	Succimer	ZNF148 ANK3 TSPOAP1 BAZ2B ETS2 ID4 TNRC6B CHD9 G2E3 ZUP1 BLM ZNF800 CELF2 FGD4 MICAL2 FMN1 N4BP2 HELZ COL14A1 NKTR KIF3C ABCC2 ARHGAP18 MGA MED13 NR1D2 IGSF3	8.68e-07	1264	171	27	ctd:D004113
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	TPR MIS18BP1 ZNF148 ANK3 BRD3 SLIT2 EFNB2 NKTR CAP2 NR1D2	1.06e-06	179	171	10	4585_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	SCAF8 PARP2 ARFGEF2 TACC2 ARID1A ADNP WDR74 SSH3 NIPBL MED13	1.23e-06	182	171	10	1951_DN
Drug	Magnetite Nanoparticles	ZNF148 ANK3 TSPOAP1 BAZ2B ETS2 ID4 TNRC6B CHD9 G2E3 ZUP1 BLM ZNF800 CELF2 FGD4 MICAL2 FMN1 N4BP2 DDX25 HELZ COL14A1 NKTR KIF3C ARHGAP18 MGA MED13 NR1D2 IGSF3	1.72e-06	1310	171	27	ctd:D058185
Drug	Epivincamine [6835-99-0]; Up 200; 11.2uM; PC3; HT_HG-U133A	SOX2 TPR PDE1C TSPOAP1 KIAA0319L GBX2 MICAL2 SNAPC4 FYB1 FAIM2	1.74e-06	189	171	10	4500_UP
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A	SOX2 TTC28 TRIO ID4 SLC12A8 SMG7 MRNIP LSM14B FYB1 PLEKHO1	2.30e-06	195	171	10	4692_DN
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SETD1A ETS2 PHTF2 SIX1 PIP5K1C OSBPL2 SMG7 MICAL2 SNAPC4 LSM14B	2.41e-06	196	171	10	6772_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	PDE1C ADAMTS3 SCAF8 GBX2 SLC12A8 ARID1A ADNP WDR74 MX1	6.65e-06	173	171	9	5950_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	SETD1A TRIO SIPA1L3 KIAA0319L SCEL ARID1A SCYL2 TDRD3 MX1	1.54e-05	192	171	9	1829_UP
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	TTC28 TRIO SIPA1L3 NUP98 PHTF2 ATP9B ADCY3 PIMREG LSM14B	1.54e-05	192	171	9	2865_DN
Drug	Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SIPA1L3 ARFGEF2 PHTF2 ID4 RRBP1 TDRD3 MRNIP LSM14B PLEKHO1	1.81e-05	196	171	9	4993_DN
Drug	Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	ANK3 SIPA1L3 PHTF2 WDR25 SCYL2 ZSCAN32 SMG7 LSM14B PLEKHO1	1.81e-05	196	171	9	4101_DN
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A	KIAA0319L ATP9B ZSCAN32 TDRD3 SMG7 SSH3 CEP250 KIF3C ABCC2	1.81e-05	196	171	9	3095_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TPR SIPA1L3 KIAA0319L ID4 SLIT2 SMG7 MICAL2 SSH3 MRNIP	1.81e-05	196	171	9	5386_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; HL60; HT_HG-U133A	SETD1A SIPA1L3 PHF8 ADCY3 TDRD3 SSH3 CEP250 MRNIP KIF3C	1.89e-05	197	171	9	1310_UP
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	MAGI1 SLC12A8 ATP9B WDR25 PIP5K1C TDRD3 OSBPL2 KIF3C SNAPC4	1.89e-05	197	171	9	3436_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	TRIO RRBP1 ADCY3 SMG7 MICAL2 SSH3 CEP250 KIF3C MAP4K4	1.96e-05	198	171	9	6983_DN
Drug	Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A	TTC28 TRIO ID4 SIX1 PIP5K1C SLIT2 TDRD3 COL14A1 FYB1	1.96e-05	198	171	9	4722_DN
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; PC3; HT_HG-U133A	ANK3 ATP9B TDRD3 NYNRIN COL14A1 PLEKHO1 OBI1 MX1 IGSF3	2.04e-05	199	171	9	7249_UP
Drug	mitoxantrone	ADCY4 ADCY3 KY CD34 ABCC2 MX1 PDZD2 BAALC	2.21e-05	154	171	8	CID000004212
Drug	chrysene	SOX2 ANK3 LCORL MUC16 CHD2 TACC2 TDRD3 HMCN1 SSH3 CD34 DDX25 AHR PIMREG NKTR LRRN4 C7 MAP4K4 NR1D2 IGSF3	3.17e-05	871	171	19	ctd:C031180
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	SCAF8 GBX2 SLC12A8 WDR25 ARID1A ADNP WDR74 NIPBL	5.07e-05	173	171	8	4458_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	PDE1C SCAF8 PARP2 GBX2 BRD3 ARID1A ADNP WDR74	5.50e-05	175	171	8	6316_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	PDE1C GBX2 SLC12A8 ARID1A ADNP WDR74 TDRD3 NIPBL	5.50e-05	175	171	8	6736_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	PDE1C SCAF8 PARP2 GBX2 ARID1A ADNP WDR74 TDRD3	5.50e-05	175	171	8	4072_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	PDE1C SCAF8 PARP2 GBX2 ARID1A ADNP WDR74 PDS5A	5.50e-05	175	171	8	7387_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BAZ2B SCAF8 PARP2 GBX2 SLC12A8 ARID1A ADNP SNAPC4	5.73e-05	176	171	8	1212_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	PDE1C SCAF8 PARP2 GBX2 ARID1A ADNP WDR74 TDRD3	6.20e-05	178	171	8	5086_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	TPR MIS18BP1 ZNF148 SCYL2 SLIT2 EFNB2 NKTR NR1D2	6.20e-05	178	171	8	3998_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SCAF8 CHD9 TACC2 ARID1A ADNP MGA NIPBL MED13	7.25e-05	182	171	8	3887_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SCAF8 PARP2 GBX2 SLC12A8 ARID1A ADNP WDR74 TDRD3	7.25e-05	182	171	8	5802_DN
Drug	Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; PC3; HT_HG-U133A	PDE1C TRIO ADAMTS3 SIPA1L3 ETS2 ATP9B SNAPC4 OBI1	7.25e-05	182	171	8	7154_UP
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	PARP2 TACC2 ARID1A ADNP BLM SNW1 EFNB2 MGA	8.76e-05	187	171	8	7080_DN
Drug	retinoic acid; Down 200; 1uM; HL60; HT_HG-U133A	SETD1A RRBP1 MICAL2 SSH3 SNAPC4 LSM14B MX1 NR1D2	9.44e-05	189	171	8	6170_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	TPR PHTF2 ARID1A ADCY3 MICAL2 SSH3 NKTR SNAPC4	1.02e-04	191	171	8	1057_DN
Drug	Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TTC28 ETS2 ID4 SLC12A8 PHF8 ARID1A ZSCAN32 SMG7	1.13e-04	194	171	8	7410_UP
Drug	Epiandrosterone [481-29-8]; Up 200; 13.8uM; PC3; HT_HG-U133A	SETD1A ANK3 BACH2 SIPA1L3 RRBP1 DDX25 COL14A1 FYB1	1.13e-04	194	171	8	4626_UP
Drug	Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A	TRIO KIAA0319L MYO1B ATP9B WDR74 SSH3 SNAPC4 PLEKHO1	1.13e-04	194	171	8	4275_DN
Drug	phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA	CENPT TRIO CHD9 TACC2 BLM SMG7 MICAL2 NKTR	1.17e-04	195	171	8	1138_DN
Drug	Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A	TRIO ID4 ADCY3 SMG7 MICAL2 SSH3 MRNIP PLEKHO1	1.17e-04	195	171	8	5520_DN
Drug	Tropine [120-29-6]; Up 200; 28.4uM; HL60; HT_HG-U133A	USP29 MC5R ARFGEF2 ATP9B MICAL2 SCG2 COL14A1 NKTR	1.17e-04	195	171	8	6147_UP
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	CENPT ADAMTS3 SIPA1L3 PHTF2 GBX2 SLC12A8 WDR74 SMG7	1.17e-04	195	171	8	1207_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A	SCAF8 SIPA1L3 PHTF2 TNRC6B MYO1B PIP5K1C SSH3 CEP250	1.17e-04	195	171	8	1214_DN
Drug	geldanamycin	TPR MIS18BP1 PHTF2 SCYL2 PLPPR4 SUPT16H AHR NKTR LSM14B NIPBL MED13	1.20e-04	371	171	11	ctd:C001277
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	SIPA1L3 KIAA0319L PHTF2 ID4 ADCY3 SMG7 CEP250 LSM14B	1.21e-04	196	171	8	5267_DN
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ID4 MYO1B SIX1 ZSCAN32 TDRD3 SMG7 LSM14B PLEKHO1	1.21e-04	196	171	8	4389_DN
Drug	Pipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A	CENPT KIAA0319L PHTF2 ADCY3 TM7SF2 NKTR KIF3C NIPBL	1.21e-04	196	171	8	3093_DN
Drug	Fluspirilen [1841-19-6]; Down 200; 8.4uM; HL60; HT_HG-U133A	SETD1A TSPOAP1 SIPA1L3 KIAA0319L MYO1B ATP9B CEP250 PLEKHO1	1.21e-04	196	171	8	3086_DN
Drug	Berberine chloride [633-65-8]; Down 200; 10.8uM; MCF7; HT_HG-U133A	PHTF2 RRBP1 SIX1 ADCY3 SLIT2 NKTR SNAPC4 PLEKHO1	1.26e-04	197	171	8	6791_DN
Drug	Benzonatate [104-31-4]; Up 200; 6.6uM; HL60; HT_HG-U133A	TSPOAP1 PHTF2 MYO1B SLC12A8 ATP9B RRBP1 TM7SF2 LSM14B	1.26e-04	197	171	8	1843_UP
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A	USP29 MC5R ID4 ATP9B SSTR1 CELF2 CD34 SNAPC4	1.26e-04	197	171	8	4315_UP
Drug	Tropine [120-29-6]; Down 200; 28.4uM; PC3; HT_HG-U133A	TPR SLC12A8 PHF8 SMG7 SCG2 SNAPC4 LSM14B IGSF3	1.30e-04	198	171	8	5790_DN
Drug	Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A	TRIO TSPOAP1 ID4 ARID1A ADGRA2 ZSCAN32 ABCC2 MX1	1.30e-04	198	171	8	3337_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A	TPR ANK3 SIPA1L3 PHTF2 MICAL2 MRNIP SNAPC4 LSM14B	1.30e-04	198	171	8	4464_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA	PHTF2 BRD3 TDRD3 PIMREG NKTR SNAPC4 PLEKHO1 NR1D2	1.30e-04	198	171	8	1042_DN
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	MIS18BP1 TTC28 SIPA1L3 PHTF2 ADCY3 SCYL2 TM7SF2 KIF3C	1.30e-04	198	171	8	2062_DN
Drug	rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A	ANK3 TRIO USP29 ID4 ARID1A SLIT2 SCG2 SIGLEC1	1.30e-04	198	171	8	6192_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	SETD1A SIPA1L3 KIAA0319L ATP9B WDR25 SSH3 CEP250 FYB1	1.30e-04	198	171	8	6196_DN
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	KIAA0319L ATP9B PHF8 WDR74 SSH3 SNAPC4 LSM14B MX1	1.35e-04	199	171	8	4294_DN
Drug	Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A	ABI1 SIPA1L3 NUP98 TACC2 RRBP1 SIX1 TDRD3 NIPBL	1.35e-04	199	171	8	7148_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	TRIO SLC12A8 PIP5K1C ZSCAN32 OSBPL2 MICAL2 SSH3 HELZ	1.40e-04	200	171	8	7015_DN
Drug	fullerene C60	VWA5B2 AHCYL1 TRIO TSPOAP1 NUP98 RTN4RL1 GBX2 SLC12A8 GRIN2D SIX1 PHC2 DNAH1 JPH1 KY LLGL2 SLC24A4 SUPT16H AHR PPP1R1C PIMREG FAIM2 MED13 NR1D2 IGSF3 PDZD2	1.43e-04	1498	171	25	ctd:C069837
Drug	2,4,4'-trichlorobiphenyl	PRUNE2 MAGI1 PRTG PDE1C TTC28 BAZ2B MYO1B SLC12A8 G2E3 ARID1A PIP5K1C JPH1 ARHGEF33 FGD4 ZSCAN30 MICAL2 PPP1R1C PIMREG C7 ABCC2 MDGA1 FAIM2 OBI1 CAP2	1.48e-04	1411	171	24	ctd:C081766
Disease	cortical thickness	VWA5B2 FNIP2 ZNF438 MAGI1 PRTG ADAMTS3 ARFGEF2 TNRC6B SLC12A8 NCKAP5 POLR2M TACC2 ADGRA2 STAU1 SLIT2 ZNF469 EFNB2 OSBPL2 SMG7 AUTS2 ARHGAP18 PDZD2	4.00e-07	1113	168	22	EFO_0004840
Disease	cortical surface area measurement	FNIP2 ZNF438 MAGI1 PRTG ABI1 ANK3 ADAMTS3 LCORL BAZ2B TNRC6B SLC12A8 NCKAP5 ADGRA2 PHC2 SLIT2 ZNF469 EFNB2 CELF2 AUTS2 MAP4K4 PDZD2	2.80e-05	1345	168	21	EFO_0010736
Disease	vital capacity	ZNF438 MROH9 ADAMTS3 LCORL ARFGEF2 ID4 SIX1 TRIP12 ADCY3 STAU1 KY LLGL2 HMCN1 AHR AUTS2 SNAPC4 SLC2A12 HMGN4 PDZD2	8.48e-05	1236	168	19	EFO_0004312
Disease	visceral adipose tissue measurement	PDE1C LCORL RTN4RL1 TRIP12 ADCY3 SLIT2 AUTS2 HELZ COL14A1 SIGLEC1 FAIM2	1.05e-04	481	168	11	EFO_0004765
Disease	body fat percentage	PDE1C LCORL PHTF2 RTN4RL1 BRD3 TRIP12 ADCY3 ENAM AUTS2 FAIM2 HOMEZ	1.19e-04	488	168	11	EFO_0007800
Disease	Neurodevelopmental Disorders	TRIO TNRC6B CHD2 ADNP TRIP12	1.96e-04	93	168	5	C1535926
Disease	blood rubidium measurement	ARFGEF2 NCKAP5 MDGA1	4.28e-04	26	168	3	EFO_0021529
Disease	Cornelia de Lange syndrome (implicated_via_orthology)	PDS5A NIPBL	4.76e-04	6	168	2	DOID:11725 (implicated_via_orthology)
Disease	Leukemia, Myelocytic, Acute	TRIO BACH2 NUP98 BLM MX1 BAALC	4.85e-04	173	168	6	C0023467
Disease	CHARGE syndrome (implicated_via_orthology)	CHD9 CHD2	6.64e-04	7	168	2	DOID:0050834 (implicated_via_orthology)
Disease	Acute Myeloid Leukemia, M1	TRIO BACH2 NUP98 MX1 BAALC	7.63e-04	125	168	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	TRIO BACH2 NUP98 MX1 BAALC	7.63e-04	125	168	5	C1879321
Disease	reticulocyte measurement	LCORL ARFGEF2 TNRC6B MYO1B SLC12A8 BRD3 ADCY3 STAU1 ZNF800 ZNF469 OSBPL2 MICAL2 SIGLEC1 HOMEZ PDZD2	1.05e-03	1053	168	15	EFO_0010700
Disease	blood titanium measurement	LCORL BAZ2B PDZD2	1.13e-03	36	168	3	EFO_0021532
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	PDE1C LCORL RTN4RL1 TRIP12 ADCY3 AUTS2 FAIM2 HOMEZ	1.20e-03	364	168	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	neuroimaging measurement	VWA5B2 ZNF438 MAGI1 PRTG ANK3 ADAMTS3 LCORL TNRC6B SLC12A8 NCKAP5 TACC2 JPH1 SLIT2 ZNF469 ARHGAP18	1.22e-03	1069	168	15	EFO_0004346
Disease	brain measurement, neuroimaging measurement	VWA5B2 ZNF438 MAGI1 PRTG ANK3 ADAMTS3 SLC12A8 NCKAP5 POLR2M SLIT2	1.27e-03	550	168	10	EFO_0004346, EFO_0004464
Disease	disposition index measurement, glucose homeostasis measurement	ZNF438 SNAPC4	1.41e-03	10	168	2	EFO_0006832, EFO_0006896
Disease	cognitive function measurement	ZNF438 MAGI1 PDE1C TTC28 LCORL CHD2 BRD3 ADGRA2 STAU1 CELF2 FGD4 FMN1 AUTS2 PDS5A KIF3C ADGRA3 NR1D2 BAALC	1.42e-03	1434	168	18	EFO_0008354
Disease	delta-5 desaturase measurement	PRTG BLM	1.71e-03	11	168	2	EFO_0007764
Disease	age at menopause	TTC28 CCNJ ADNP ADGRA2 TDRD3 LRRN4 MGA	1.79e-03	302	168	7	EFO_0004704
Disease	metabolite measurement, body weight gain	TACC2 KIF19	2.05e-03	12	168	2	EFO_0004566, EFO_0004725
Disease	polychlorinated biphenyls measurement, gestational serum measurement	NCKAP5 FMN1	2.05e-03	12	168	2	EFO_0007042, EFO_0007964
Disease	multiple sclerosis	ZNF438 SETD1A TTC28 TSPOAP1 CDHR3 BACH2 NCKAP5 ADCY3 N4BP2 UCK2	2.23e-03	594	168	10	MONDO_0005301
Disease	aspartate aminotransferase to alanine aminotransferase ratio	PRUNE2 ARID1A ZNF251 NYNRIN AUTS2 ABCC2	2.55e-03	239	168	6	EFO_0010934
Disease	pancreatic cancer (is_marker_for)	MUC16 AHR UCK2 ABCC2	2.70e-03	101	168	4	DOID:1793 (is_marker_for)
Disease	phoneme awareness	ARFGEF2 STAU1	2.80e-03	14	168	2	EFO_0021812
Disease	Birth Weight	LCORL AHR	2.80e-03	14	168	2	C0005612
Disease	serum IgG glycosylation measurement	MAGI1 BACH2 CHD2 TRAM1L1 FMN1 AUTS2 MDGA1 MARCOL MX1	3.18e-03	523	168	9	EFO_0005193
Disease	arm span	CDHR3 AUTS2	3.22e-03	15	168	2	EFO_0005108
Disease	4-acetamidobutanoate measurement	POLR2M OBI1	3.67e-03	16	168	2	EFO_0021003
Disease	T-Cell Lymphoma	ARID1A MGA	3.67e-03	16	168	2	C0079772
Disease	urinary albumin to creatinine ratio	PHC2 CELF2 AHR AUTS2 MGA	3.68e-03	179	168	5	EFO_0007778
Disease	schizophrenia, intelligence, self reported educational attainment	FNIP2 PDE1C LCORL BRD3 STAU1 PLEKHO1 NR1D2	3.80e-03	346	168	7	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO MED13	4.14e-03	17	168	2	DOID:0060307 (is_implicated_in)
Disease	Fetal Alcohol Syndrome	ANK3 ADNP	4.14e-03	17	168	2	C0015923
Disease	Amelogenesis imperfecta	ENAM SLC24A4	4.14e-03	17	168	2	cv:C0002452
Disease	lymphocyte count	FNIP2 TTC28 PCDHGB6 LCORL PCDHGA11 BACH2 TNRC6B BRD3 TRIP12 ZNF800 ZNF469 TAF8 OSBPL2 AUTS2 HELZ SIGLEC1 OBI1	4.27e-03	1464	168	17	EFO_0004587
Disease	total blood protein measurement	ZNF438 BACH2 PHTF2 RRBP1 DNAH1 NYNRIN CD34 SIGLEC1	4.34e-03	449	168	8	EFO_0004536
Disease	cognitive function measurement, self reported educational attainment	PDE1C LCORL ARFGEF2 STAU1 ZNF800 AUTS2 NR1D2	4.36e-03	355	168	7	EFO_0004784, EFO_0008354
Disease	cancer (implicated_via_orthology)	ARID1A PIP5K1C TRIP12 PHC2 LLGL2 NIPBL	4.46e-03	268	168	6	DOID:162 (implicated_via_orthology)
Disease	Schizophrenia	MAGI1 SETD1A ANK3 ADAMTS3 MC5R GRIN2D ADNP EFNB2 CELF2 AUTS2 ARHGAP18 MDGA1	4.81e-03	883	168	12	C0036341
Disease	Abnormality of chromosome segregation	USP29 MC5R FYB1	4.89e-03	60	168	3	HP_0002916
Disease	metabolite measurement	MROH9 SETD1A ANK3 ZNF251 SLIT2 MICAL2 AHR ABCC2 MDGA1	4.96e-03	560	168	9	EFO_0004725
Disease	lingual gyrus volume measurement	NCKAP5 EFNB2	5.17e-03	19	168	2	EFO_0010314
Disease	neuroticism measurement, cognitive function measurement	LCORL ARID1A ADCY3 STAU1 SCAF1 CELF2 N4BP2 AUTS2 NR1D2	5.31e-03	566	168	9	EFO_0007660, EFO_0008354

Protein segments in the cluster

Peptide	Gene	Start	Entry
ALKSSPTERNGGQDN	AHR	86	P35869
QQSQSVKQLLPSGNG	ADNP	361	Q9H2P0
GKTQNGQDKTNAPSR	ADNP	691	Q9H2P0
GQDKTNAPSRLNQSP	ADNP	696	Q9H2P0
NSSNSLKPGLARGQI	BACH2	261	Q9BYV9
GRKPAAGAQSAGTQQ	BRD3	156	Q15059
LLQQQSAAGSQKEGP	CELF2	406	O95319
TLGNILPVSKNGNAQ	ADGRF1	486	Q5T601
QNPKAGNSRASLEAG	ADGRA2	956	Q96PE1
TSGKSNRNGPEKGVN	BAZ2B	156	Q9UIF8
SVQNGLPKSRLGNNE	ADGRA3	1201	Q8IWK6
DKNPSERGQSQLSNP	ARFGEF2	1516	Q9Y6D5
DQNPRQDQKGGFRSS	ARHGEF33	806	A8MVX0
NKQRGQAGPQSAQLS	CCNJ	246	Q5T5M9
ASGAKVNQPRQDGTA	ANKRD29	166	Q8N6D5
GNNQPARTGTLSRTN	ABI1	161	Q8IZP0
RLQAGQGSRPESTNN	ADCY4	246	Q8NFM4
RNKENLQPQSSGVQG	CUEDC2	91	Q9H467
VSGQSNGRDPQALAK	AGO3	831	Q9H9G7
GSLNPSLNEENVKGQ	CCDC180	746	Q9P1Z9
NVLSSRGPQNSNTRG	CCDC14	726	Q49A88
PQNLIAQSQSGTGKT	DDX25	136	Q9UHL0
NDLNQGGPGSTNSKR	ZFYVE19	281	Q96K21
NSANGVSSKPLQNGR	SLC24A4	356	Q8NFF2
NRNQISKAGAGKQAP	RTN4RL1	361	Q86UN2
GSVLRSNSPGNQESQ	RBM44	296	Q6ZP01
GRRPKSESQGNATKN	PDS5A	1271	Q29RF7
VAGNSIRENGAKSQP	TSPOAP1	1286	O95153
QGKERQGDRSSQSPA	FMN1	386	Q68DA7
PGSNATLTNAAGKRD	PCDHGA11	901	Q9Y5H2
NTEGPSLLNQKGTAV	SLC2A12	6	Q8TD20
PGSNATLTNAAGKRD	PCDHGB6	896	Q9Y5F9
ALNESKRVNNGNTAP	PARP2	16	Q9UGN5
QAKQGTPRAQASREG	MRNIP	261	Q6NTE8
KNSNGNAGPRPALNN	ARID1A	101	O14497
QNALTQNPKRSPNTG	MDGA1	776	Q8NFP4
SKGSSPRLNTQGNTA	MUC16	1716	Q8WXI7
RRDSPLQGSGQQNSQ	MAP4K4	636	O95819
NRKGPQNQVGAGTTT	NUP98	211	P52948
LSVANKAPGTEGQQQ	FAIM2	6	Q9BWQ8
SRNSSLLEPQKSGNN	MIS18BP1	131	Q6P0N0
KRTPQGSQNSLNTVS	MAGI1	956	Q96QZ7
AQEGSAKAERPGLQN	LLGL2	676	Q6P1M3
NANQNASPNVPGKRG	MGA	601	Q8IWI9
KTQGPDGVQLENANS	KIAA0319L	636	Q8IZA0
SDQQANPSSLLQRGG	KY	31	Q8NBH2
TGTQLNGRQAQPSSK	LSM14B	181	Q9BX40
NGRQAQPSSKTASDV	LSM14B	186	Q9BX40
SQAGGNNTGSTPLRK	ATP9B	511	O43861
SGKTQENRNGSIGPS	LCORL	176	Q8N3X6
NKLPANVRQSLGNSQ	FAM91A1	16	Q658Y4
QNPSSGARLNQDKRS	JPH1	486	Q9HDC5
SLRAQGGQTQSPTKS	CAP2	291	P40123
DLAGSERQNKAGPNT	KIF3C	246	O14782
TLATPKRSGNNNGSE	EFNB2	271	P52799
KRSGNNNGSEPSDII	EFNB2	276	P52799
VNGTRANKSDNPRGK	PDE1C	576	Q14123
KPSGSQTVNLTGRAN	PDZD2	1136	O15018
TSQEQRQGAPGNHSK	PDZD2	1346	O15018
SNLNLLTNNSGTPKD	ETS2	261	P15036
LPQRQGNDTDKTQGA	FGD4	71	Q96M96
PNSSSGIQARKNLFN	FYB1	26	O15117
GNNPAKNRDASTLQS	HMGN4	66	O00479
NKQNNGRSETTKSRP	NIPBL	686	Q6KC79
SKNQGDSARKQPGSS	OBI1	291	Q5W0B1
RISPTAGNQNGLLNK	AUTS2	1196	Q8WXX7
MSSRKQGSQPRGQQS	MORF4L2	1	Q15014
QEKSSQQNSGARLPG	ABCC2	261	Q92887
QQNSGARLPGLNKNQ	ABCC2	266	Q92887
ARLPGLNKNQSQSQD	ABCC2	271	Q92887
TNIDNGQKSSDGPIQ	MED29	86	Q9NX70
EPGQQGLQAAARSAK	PIMREG	76	Q9BSJ6
TALNTDPAGAVNKQG	ID4	141	P47928
ARCQNDIGTNKPTNG	MROH9	201	Q5TGP6
QNRNGKSDTNNSGPE	HELZ	1276	P42694
PVNTAQGNLKIQSSG	HMCN1	1866	Q96RW7
SKTAQNGTQQLPRTS	PRTG	981	Q2VWP7
GANSQKNTFRKNPSD	TM7SF2	306	O76062
KGNRQRTQEPTAANQ	KIF19	201	Q2TAC6
QSPGSQSKDLLRQGS	G2E3	326	Q7L622
QLQPKSSSAGSQGRE	DNAH1	3971	Q9P2D7
NSKPDGANLRQRSAQ	ADAMTS3	1121	O15072
LSKGAGQTNVPNLVN	CHD9	1121	Q3L8U1
KAGNANSKTGEPSRN	GBX2	306	P52951
SRNSSKNSDGKNGVP	IGSF3	1151	O75054
KNAPAGQETQRGGSK	BLM	91	P54132
LENNSGRSNSNPFNK	CHD2	951	O14647
NKATGQGRENRDQPQ	LINC00322	176	Q6ZN03
SRNEGGKLGNPKNRN	CDHR3	856	Q6ZTQ4
PTSGGKTNQLNLQNT	COL14A1	66	Q05707
DPNLGKLNTNQNSLG	FNIP2	196	Q9P278
KLNTNQNSLGPCRTG	FNIP2	201	Q9P278
QAAGRKTQSSGPGLQ	CENPT	271	Q96BT3
SSPTQQDGRGQKNSD	CEP250	2331	Q9BV73
KAASGTQNNVLRGEP	C7	361	P10643
PQNLIAQSQSGTGKT	DDX19B	131	Q9UMR2
ENQNKSGSEAGSPRR	CTR9	1061	Q6PD62
KTATQNGLNGSALPN	ADCY3	501	O60266
RNANVNLSNKSGLTP	ANK3	686	Q12955
QSLSSGPLTQKQNGL	BAALC	91	Q8WXS3
DLNLNATEGNLSGPN	MC5R	11	P33032
QSLQAANKSGTQRSP	KHDC3L	181	Q587J8
SRKVPNSDGQTQSQN	ENAM	501	Q9NRM1
NSDGQTQSQNLPKGI	ENAM	506	Q9NRM1
SGLSKEQAGRGPNQS	HOMEZ	226	Q8IX15
IKSSQTSQNQGLGRP	POLR2M	121	P0CAP2
KLESSQPRQGEGNRT	SLC12A8	471	A0AV02
GATSQRKGDNVPQVN	SCAF8	1201	Q9UPN6
SPEAQGKASVNRGAQ	CD34	346	P28906
SARNGSRKNQGVPQI	COL6A6	321	A6NMZ7
GDQQSVSKAPNVGSR	LRRN4	401	Q8WUT4
SNKDGDQHSPGRNQS	MICAL2	1581	O94851
QNRGPENSKRLSSLG	NYNRIN	251	Q9P2P1
SSNSDTNGNPKNGDL	NR1D2	46	Q14995
SVLQQNPSLSGSRNG	TAF8	271	Q7Z7C8
PGRNASQNGTLSEGQ	SSTR1	41	P30872
TAAAAGGNQKNSPDR	SOX2	26	P48431
NTGTLRNGPSKDTQR	PHTF2	311	Q8N3S3
QNSKSVLEGSGLPRN	TDRD3	341	Q9H7E2
QQSSRNRISSGPGNL	PRUNE2	1016	Q8WUY3
GNQAETKNRLPGSQL	PRUNE2	2441	Q8WUY3
DNPDGGLQSKNNRRT	NCKAP5	1576	O14513
EGSCSNSENNRGKPQ	NKTR	961	P30414
PREKQQTNSKGSSNF	AHCYL1	91	O43865
QGAQSTSDEKRPVGQ	PIP5K1C	336	O60331
DKRGPNTQGELQNAS	PPP1R1C	51	Q8WVI7
GANRNRKTNGSIPQT	GOLGA8M	31	H3BSY2
SSQQGNQGPSSKQRK	MARCOL	261	A0A1B0GUY1
TLQGQAKNRANPNRS	SMG7	71	Q92540
SNQVKRVPGQGSSED	SCG2	521	P13521
TGQSPQKGLQRTLSD	SIPA1L3	1531	O60292
PTDNTKRNLTNGLNA	SCYL2	761	Q6P3W7
SSNKQNQLSPLEGGK	SIX1	196	Q15475
NLKSRNAGQQGQAPS	MED13	431	Q9UHV7
TKGNENANGAPAITL	SUPT16H	91	Q9Y5B9
NSAKRGPQDGNQQPA	PLEKHO1	6	Q53GL0
ATRESPKANGQNQAS	SETD1A	561	O15047
NNRIGKTGERPSQEN	OSBPL2	41	Q9H1P3
FGQGSQSPQKQEEQR	SSH3	81	Q8TE77
SQENSPALLGVQKGT	ANKHD1	736	Q8IWZ3
GKRFRPNQQQQAGKS	ZNF837	231	Q96EG3
QASVTQLAPGRGSNN	TSACC	91	Q96A04
NQDPNRLLSAKNGSS	PLPPR4	351	Q7Z2D5
QRKQAANFTAGGQPR	WDR74	26	Q6RFH5
AQSRNTAQASPAGAK	PHC2	266	Q8IXK0
LAGSQNRNPDALTGN	TRAM1L1	276	Q8N609
NAAGNKISQLPSQDR	ZSCAN30	241	Q86W11
KDPTQGQKSALQGNS	ZSCAN32	16	Q9NX65
PTQGRKAEGAQNQAK	RRBP1	286	Q9P2E9
PSAALSGSQILNKNQ	STAU1	11	O95793
ESGRSQSGSPNKQRD	SRRM5	386	B3KS81
ASQSSQRTGKGQPSN	TPR	916	P12270
QAVGSSLQGDLPNDK	SCAF1	41	Q9H7N4
TKLQPGGSLNANTSN	SCEL	131	O95171
GKPAQLGTQRSQEAD	TNKS1BP1	826	Q9C0C2
NPGNKNILDAENTRG	USP29	791	Q9HBJ7
GKSNVASLRQAPGQN	SLIT2	1286	O94813
TGQGPNKSQQALADA	TACC2	986	O95359
PSQQGVAFNSGAKQR	SNW1	181	Q13573
QGQDPARSVTFNSQK	SIGLEC1	176	Q9BZZ2
QDILNGGPSKRQTNG	UCK2	226	Q9BZX2
PGGTESQSLRTNENK	ARHGAP18	186	Q8N392
AEKTQGQGTANQLQP	ZNF469	1961	Q96JG9
QRSGGQVSKSNNPED	TTC28	2181	Q96AY4
DQNGNSKRALGDPAT	VWA5B2	1001	Q8N398
DPQGASQLNNRLQGT	ZUP1	406	Q96AP4
RVGNSAGQSLNKPNI	ZNF251	146	Q9BRH9
LSGTNSKREKGPNNT	ZNF800	386	Q2TB10
SVGSQSNQAGQGKRP	PHF8	1021	Q9UPP1
SGLGQSQAPAASRKQ	SNAPC4	1021	Q5SXM2
GAQDQRSTPTNQKGS	TEX33	126	O43247
TQFSTANGQVNLRGP	ZNF148	746	Q9UQR1
NATGQQKDTSGVARP	WDR25	31	Q64LD2
SSQQPGQDALAVKAG	ZBED1	101	O96006
QSNSNNIEPARTAGG	TRIP12	1056	Q14669
NIPSGTIQSRKGLQN	ZNF438	16	Q7Z4V0
NSGSGNADLQNLLPK	TRIO	296	O75962
DGPKNGNTNSLNLSS	TNRC6B	371	Q9UPQ9
EAQGLAGAQVSKPQN	nan	141	Q96M85
PGNKGSNALLRNSGS	ZC3H8	151	Q8N5P1
GANRNRKTNGSIPQT	GOLGA8IP	31	A6NC78
VSQSEPKGNGNINKR	KCNH8	691	Q96L42
IQGNQKNGSVPTCKR	MYO1B	1111	O43795
LLNGDATVAQKNPGS	MX1	21	P20591
TGLDNPEQKSSQRTG	N4BP2	1451	Q86UW6
GTVPNGSTEKNIRSN	GRIN2D	711	O15399